基本分析
透過季節調整季營收，判斷美股整體趨勢，但注意股價有時候領先基本面的數據，應搭配其他領先指標判斷。
基本資料
個股的基本資料，以及所屬的類股和產業。
公司介紹
業務介紹
默克（Merck & Co., Inc.）是一家在全球範圍內經營的醫療保健公司。它通過兩個部門運營，即製藥和動物健康。製藥部門提供人類健康製藥產品，涵蓋腫瘤學、醫院急性護理、免疫學、神經科學、病毒學、心血管和糖尿病領域，以及預防性兒科、青少年和成人疫苗產品。動物健康部門發現、開發、製造和銷售獸醫藥品、疫苗和健康管理解決方案和服務，以及數字連接的識別、追踪和監測產品。它為藥品批發商和零售商、醫院和政府機構提供服務；管理醫療保健提供者，如健康維護組織、藥物效益管理者和其他機構；以及醫生和醫生分銷商、獸醫和動物生產者。該公司與阿斯利康（AstraZeneca PLC）、拜耳（Bayer AG）、榮偉生物製藥（Eisai Co., Ltd.）、Ridgeback Biotherapeutics和吉利德科學公司（Gilead Sciences, Inc.）合作，共同開發和商業化長效治療艾滋病。默克（Merck & Co., Inc.）成立於1891年，總部位於新澤西州肯尼爾沃思。
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
警語
1. 資料僅供參考，不做任何獲利保證及特定股票與點位推薦建議。
2. 資料並不完整，需要完整資料請至相關網站索取。
3. 任何股市數據分析皆存在倖存者偏差。
